Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells

Published:2012-07 Issue:1 Volume:57 Page:108-115
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Blivet-Van Eggelpoël Marie-José,Chettouh Hamza,Fartoux Laetitia,Aoudjehane Lynda,Barbu Véronique,Rey Colette,Priam Sabrina,Housset Chantal,Rosmorduc Olivier,Desbois-Mouthon Christèle

Publisher

Elsevier BV

Subject

Hepatology

Reference30 articles.

1. Pathogenesis of hepatocellular carcinoma and molecular therapies;Minguez;Curr Opin Gastroenterol,2009

2. Molecularly targeted therapy in hepatocellular carcinoma;Huynh;Biochem Pharmacol,2010

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

4. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

5. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling;Wilhelm;Mol Cancer Ther,2008

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1);Journal of Hepatocellular Carcinoma;2024-05

2. Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC;Molecular Cancer;2024-04-06

3. DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis;Molecular Therapy;2024-04

4. SERPINE2 promotes liver cancer metastasis by inhibiting c‐Cbl‐mediated EGFR ubiquitination and degradation;Cancer Communications;2024-02-26

5. A highly oxidized germacranolide from elephantopus tomentosus inhibits the growth of hepatocellular carcinoma cells by targeting EGFR in vitro and in vivo;Bioorganic Chemistry;2024-02